[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_7130 

# __Inadequate evaluation of drugs for covid-19 therapy__

## Articles mentionning the risk

* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)

## Mitigations of this risk

* [Conducting adequate studies with realistic eligibility criteria and patient stratification](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_9011.md)

## Name of the risk

Ineffective treatment for COVID-19 patients

## People affected by this risk

* [Covid-19 patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_501.md)

## Stakeholders who can mitigate this risk

* [Medical research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1293.md)
* [Regulatory authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_4250.md)

## Technologies linked to the risk

* [Medical research and clinical trial technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8685.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Failure to implement preventive measures](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_12.md)

